Phillips Medisize to Present Strategies for Scaling Complex In Vitro Diagnostic (IVD) Builds Through Structured CDMO Collaboration at ADLM 2026
Phillips Medisize, a Molex company and a leader in the design, engineering and manufacturing of in vitro diagnostic, pharmaceutical drug delivery and medtech devices, announced it will deliver a lecture series spotlight at the Association for Diagnostics & Laboratory Medicine (ADLM) 2026 Annual Meeting, taking place July 26-30 in Anaheim, CA. The session, titled "Designing for Scale through CDMO Collaboration: Lessons from Complex IVD Builds," will be led by Pradnya Parulekar, MPP, MBA, M.S. Finance, Associate Director of Business Development at Phillips Medisize.
Phillips Medisize to Showcase Advances in Inhalation and Dry Powder Inhaler Innovations at Respiratory Drug Delivery (RDD) 2026
Phillips Medisize, a Molex company and a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, today announced it will present scientific research at the Respiratory Drug Delivery (RDD) 2026 Conference, taking place May 10–14, 2026, in Phoenix, Arizona.
Phillips Medisize Highlights Inhaled Drug Delivery Device Platforms and Scientific Insights at DDL 2025
Phillips Medisize, a Molex company and a leader in the design, development, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, will showcase its inhaled drug delivery device and formulation platforms and capabilities at the Drug Delivery to the Lungs conference (DDL 2025) in Edinburgh, Scotland, December 10–12. The company will also share insights through a podium presentation and multiple poster sessions.
Phillips Medisize Launches TheraVolt Medical Connectors to Support Next-Gen Device Integration, Connectivity and Performance
Phillips Medisize, a Molex company and a leader in the design, engineering and manufacturing of medtech, pharmaceutical drug delivery and in vitro diagnostic devices, announces the launch of TheraVolt™ Medical Connectors. As the first medical connectors launched under the Phillips Medisize brand, TheraVolt is engineered to optimize device integration, functionality, reliability and performance. TheraVolt provides device engineers enhanced functionality, offering solutions to handle both signals and high voltage lines.
Phillips Medisize Announces Scientific Presentations and Engagements at Respiratory Drug Delivery Conference, Highlighting Its Expanded Inhalation Drug Delivery Capabilities
Phillips Medisize, a Molex company and a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, announced scientific presentations and engagements at the Respiratory Drug Delivery (RDD) conference in Lisbon, Portugal, May 6–9, 2025. The company’s experts will lead a panel discussion, sponsored workshop and several poster presentations that highlight innovations and developments in inhalation product development.
